De novo lipogenesis in health and disease

2014/04/12 by Fatima Ameer, Lisa Scandiuzzi, Shahida Hasnain +2 · 606 citations
Biochemistry, Genetics and Molecular Biology · Medicine · Nursing · #Adipose tissue #Biology #Cancer, Lipids, and Metabolism #Diabetes, Cardiovascular Risks, and Lipoproteins #Disease #Endocrinology #Energy homeostasis #Fatty Acid Research and Health #Fatty liver #Internal medicine #Lipogenesis #Medicine #Metabolic pathway #Metabolic syndrome #Metabolism #Obesity

paper · doi:10.1016/j.metabol.2014.04.003

published in Metabolism 63(7), 895-902 (Elsevier BV)

openalex publication_date 2014/04/12 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/04

Citations

• Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

Cited by

• Metabolism
• The protein denitrosylase SCoR2 regulates lipogenesis and fat storage
• Intramuscular fat deposition in pig: A key target for improving pork quality
• ChREBP-mediated regulation of lipid metabolism in liver and brown adipose tissue of long-lived mice
• CD47 antisense oligonucleotide treatment improves glucose homeostasis and alleviates dyslipidemia in aged male mice
• Induction of a metabolic switch from glucose to ketone metabolism programs ketogenic diet-induced therapeutic vulnerability in lung cancer
• Amyloid-β induces lipid droplet-mediated microglial dysfunction via the enzyme DGAT2 in Alzheimer’s disease
• The endogenous molecular clock orchestrates the temporal separation of substrate metabolism in skeletal muscle. [europepmc]
• Hepatic Steatosis as a Marker of Metabolic Dysfunction. [europepmc]
• Acute Respiratory Distress Syndrome: Role of Oleic Acid-Triggered Lung Injury and Inflammation. [europepmc]
• Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals. [europepmc]
• Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2(+) Breast Cancer. [europepmc]
• Fatty acid metabolism and the basis of brown adipose tissue function. [europepmc]
• Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase. [europepmc]
• SREBP-1 is an independent prognostic marker and promotes invasion and migration in breast cancer. [europepmc]
• Adipose tissue lipolysis and remodeling during the transition period of dairy cows. [europepmc]
• Spatial Organization of Metabolic Enzyme Complexes in Cells. [europepmc]
• Pathophysiology of Type 2 Diabetes in Children and Adolescents. [europepmc]
• Regulation and Metabolic Significance of De Novo Lipogenesis in Adipose Tissues. [europepmc]
• Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects to Improve Blood Sugar Levels. [europepmc]
• The small intestine shields the liver from fructose-induced steatosis. [europepmc]
• Metabolism. [europepmc]
• Wnt/β-catenin signaling regulates adipose tissue lipogenesis and adipocyte-specific loss is rigorously defended by neighboring stromal-vascular cells. [europepmc]
• The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives. [europepmc]
• Monounsaturated Fatty Acids in Obesity-Related Inflammation. [europepmc]
• Visceral Adiposity and Cancer: Role in Pathogenesis and Prognosis. [europepmc]
• Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy. [europepmc]
• Impact of Dietary Palmitic Acid on Lipid Metabolism. [europepmc]
• Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH). [europepmc]
• Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. [europepmc]
• Metabolic Signatures of Youth Exposure to Mixtures of Per- and Polyfluoroalkyl Substances: A Multi-Cohort Study. [europepmc]
• Amyloid-β induces lipid droplet-mediated microglial dysfunction via the enzyme DGAT2 in Alzheimer's disease. [europepmc]